Qt Imaging Holdings (QTIWW) Cash from Financing Activities (2021 - 2026)
Qt Imaging Holdings (QTIWW) reported Cash from Financing Activities of $159000.0 for Q1 2026, down 97.03% year-over-year from $5.4 million in Q1 2025, and down 98.66% on a QoQ basis from $11.9 million in Q4 2025.
Qt Imaging Holdings (QTIWW) has 6 years of Cash from Financing Activities data on file, last reported at $159000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 97.03% year-over-year to $159000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (up 160.65% YoY) and the FY2025 annual result came in at $18.4 million, up 64.93% from the prior year.
- Cash from Financing Activities eased to $159000.0 in Q1 2026 per QTIWW's latest filing, from $11.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $11.9 million in Q4 2025 and bottomed at -$1.2 million in Q3 2024.
- The 5-year median for Cash from Financing Activities is $623485.0 (2022), against an average of $2.3 million.
- The widest annual swing landed in 2024, when Cash from Financing Activities slumped 540.06%; it then soared 1709.06% in 2025.
- Tracing QTIWW's Cash from Financing Activities over 5 years: stood at $675000.0 in 2022, then increased by 18.91% to $802612.0 in 2023, then climbed by 13.07% to $907525.0 in 2024, then soared by 1211.84% to $11.9 million in 2025, then tumbled by 98.66% to $159000.0 in 2026.
- Per Business Quant, the three latest QTIWW Cash from Financing Activities figures stand at $159000.0 (Q1 2026), $11.9 million (Q4 2025), and $571970.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Qt Imaging Holdings | - | - | 2.67 Mn | 159,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159,000.00 |
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 11.91 Mn |
| Dec 31, 2025 | 11.91 Mn |
| Sep 30, 2025 | 571,970.00 |
| Sep 30, 2025 | 571,970.00 |
| Jun 30, 2025 | 523,716.00 |
| Jun 30, 2025 | 523,716.00 |
| Mar 31, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 907,525.00 |
| Dec 31, 2024 | 907,525.00 |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | -32,548.00 |
| Jun 30, 2024 | -32,548.00 |
| Mar 31, 2024 | 11.43 Mn |
| Mar 31, 2024 | 11.43 Mn |
| Dec 31, 2023 | 802,612.00 |
| Dec 31, 2023 | 802,612.00 |
| Sep 30, 2023 | 267,700.00 |
| Sep 30, 2023 | 267,700.00 |
| Jun 30, 2023 | 387,784.00 |
| Jun 30, 2023 | 387,784.00 |
| Mar 31, 2023 | 915,697.00 |
| Mar 31, 2023 | 915,697.00 |
| Dec 31, 2022 | 675,000.00 |
| Dec 31, 2022 | 675,000.00 |
| Dec 31, 2021 | -286,236.00 |
| Dec 31, 2021 | -286,236.00 |
| Sep 30, 2021 | 234.33 Mn |
| Sep 30, 2021 | 234.33 Mn |
| Mar 31, 2021 | 45,212.00 |
| Mar 31, 2021 | 45,212.00 |